V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260018093 | 260018185 | 1.83 | 72.6 | Palliative (P) | 2018-08-24 | 2018-08-24 | POMB | N | N | 260029021 | BLEOMYCIN |
| 260018094 | 260014576 | 1.81 | 138.2 | Disease modification (D) | 2014-03-07 | 2014-03-15 | GEMCITABINE + TIP | 2 | N | 260029029 | CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 260018095 | 260009614 | 1.83 | 77 | Disease modification (D) | 2018-04-21 | 2018-04-24 | CISPLATIN + IFOSFAMIDE + PACLITAXEL | 02 | N | 260029033 | VINORELBINE |
| 260018097 | 260009623 | 1.66 | 66.6 | Curative (C) | 2018-07-14 | 2018-07-19 | Carboplatin + Etoposide IV 3 day | 02 | N | 260029065 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260018098 | 260018789 | 1.58 | 72.6 | Curative (C) | 2018-05-17 | 2018-05-17 | CVP | 2 | N | 260029067 | BLEOMYCIN + VINCRISTINE |
| 260018099 | 260009631 | 1.83 | 81.7 | Curative (C) | 2018-07-29 | 2018-08-30 | VIP | N | N | 260029080 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260018100 | 260009634 | 1.71 | 69.3 | null | 2016-06-04 | 2016-09-04 | Gemcitabine + Oxaliplatin | N | N | 260029096 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260018101 | 260014589 | 1.74 | 91.9 | Curative (C) | 2016-11-27 | 2016-12-07 | CYCLOPHOSPHAMIDE | N | N | 260029129 | CARBOPLATIN + PACLITAXEL |
| 260018102 | 260009646 | null | null | null | 2017-05-20 | 2017-06-05 | Gemcitabine + Oxaliplatin | N | N | 260029135 | IVA |
| 260018103 | 260009649 | 1.62 | 63.1 | Curative (C) | 2018-10-22 | 2018-11-16 | Docetaxel + Trastuzumab (Maint) | N | N | 260029137 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260018104 | 260009654 | 1.76 | 67.3 | Not known (9) | 2016-02-24 | 2016-02-24 | Methotrexate High Dose (3g/m2) | 2 | N | 260029145 | CAPECITABINE + OXALIPLATIN |
| 260018105 | 260009661 | null | null | Curative (C) | 2018-09-21 | 2018-09-25 | CISPLATIN + EPIRUBICIN | N | null | 260029169 | IFOSFAMIDE + PACLITAXEL |
| 260018106 | 260009663 | 1.63 | 57.1 | Curative (C) | 2015-06-17 | 2015-10-20 | CISPLATIN + GEMCITABINE + RITUXIMAB | N | N | 260029198 | ICE |
| 260018107 | 260014595 | null | 71.5 | null | 2015-09-04 | 2015-09-19 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL | N | N | 260029201 | BLEOMYCIN + VINCRISTINE |
| 260018108 | 260009666 | 1.72 | null | Palliative (P) | 2018-07-22 | 2018-07-22 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 02 | N | 260029207 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260018109 | 260009672 | 1.67 | 78.4 | Palliative (P) | null | 2017-05-11 | Methotrexate High Dose (3g/m2) | 2 | N | 260029223 | GEMCITABINE + PACLITAXEL |
| 260018110 | 260009674 | 1.7 | null | Palliative (P) | 2015-02-13 | 2015-02-19 | Cyclophosphamide High Dose | 02 | N | 260029231 | CARBOPLATIN + ETOPOSIDE |
| 260018111 | 260014601 | 1.76 | 72.6 | Disease modification (D) | 2017-10-14 | 2017-10-28 | BLEOMYCIN | N | N | 260029236 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + METHOTREXATE |
| 260018112 | 260009679 | 1.66 | 80.6 | Curative (C) | 2016-12-04 | 2016-12-11 | STS Rhabdomyosarcoma RMS 2005 IVA | null | null | 260029241 | METHOTREXATE + VINCRISTINE |
| 260018113 | 260009688 | 1.75 | 80.6 | null | 2019-06-04 | 2019-06-05 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 2 | N | 260029259 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260018114 | 260009692 | 1.85 | 76.5 | Curative (C) | 2018-03-13 | 2018-07-29 | Dacarbazine | N | N | 260029288 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260018115 | 260009694 | 1.81 | 89 | Curative (C) | 2017-11-24 | 2017-11-24 | Gemcitabine + Oxaliplatin | N | N | 260029313 | IFOSFAMIDE + PACLITAXEL |
| 260018116 | 260009700 | null | null | Curative (C) | 2015-06-27 | 2015-07-01 | POMB | N | N | 260029334 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 260018117 | 260009701 | 1.7 | 79 | Palliative (P) | 2018-04-30 | 2018-05-04 | LIPOSOMAL DOXORUBICIN | 02 | N | 260029335 | NIVOLUMAB |
| 260018118 | 260009702 | 1.77 | 83.9 | Curative (C) | 2015-05-12 | 2015-05-12 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | N | null | 260029338 | CARBOPLATIN + PACLITAXEL |
| 260018119 | 260014611 | 1.77 | 76.7 | Curative (C) | 2014-05-26 | 2014-05-26 | Gemcitabine + Oxaliplatin | N | N | 260029342 | IPO |
| 260018120 | 260009704 | 1.69 | 68.6 | Curative (C) | 2015-02-20 | 2015-02-20 | Gemcitabine + Oxaliplatin | N | N | 260029348 | POMB |
| 260018121 | 260009708 | 1.77 | 65.9 | Palliative (P) | 2016-07-19 | 2017-03-12 | CARBOPLATIN + EPIRUBICIN + ETOPOSIDE + MELPHALAN | N | N | 260029356 | CARBOPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE |
| 260018122 | 260017002 | 1.8 | 61.7 | null | 2016-12-12 | 2016-12-24 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | null | 260029366 | CARBOPLATIN + PACLITAXEL |
| 260018123 | 260009718 | 1.72 | 69.8 | null | 2018-05-22 | 2018-07-23 | Cyclophosphamide PO +Vinorelbine IV | N | N | 260029384 | BLEOMYCIN |
| 260018124 | 260009724 | 1.73 | 115.7 | Curative (C) | 2015-04-22 | 2015-04-22 | CARBOPLATIN + ETOPOSIDE | null | null | 260029421 | CARBOPLATIN + PEMETREXED |
| 260018125 | 260009729 | 1.76 | 51 | Curative (C) | 2018-05-17 | 2018-05-17 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 02 | N | 260029426 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260018126 | 260009731 | null | 91 | Curative (C) | 2014-11-06 | 2014-11-21 | BLEOMYCIN | N | N | 260029427 | ACE (GERM CELL) |
| 260018127 | 260009732 | 1.72 | 60 | Curative (C) | 2017-01-20 | 2017-01-21 | Gemcitabine + Oxaliplatin | N | N | 260029433 | GEMCARBO |
| 260018128 | 260009735 | 1.64 | 63.1 | Palliative (P) | 2018-03-08 | 2018-03-08 | TRASTUZUMAB | N | N | 260029448 | DOCETAXEL + TRASTUZUMAB |
| 260018129 | 260009737 | 1.58 | 46.6 | Palliative (P) | 2015-04-26 | 2015-04-29 | NIVOLUMAB | N | N | 260029461 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260018130 | 260009739 | 1.76 | 70 | Curative (C) | 2017-12-16 | 2017-12-22 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | 260029464 | GEMCARBO |
| 260018131 | 260009743 | 1.66 | 72 | Curative (C) | 2016-11-28 | 2016-11-28 | CISPLATIN + ETOPOSIDE + PACLITAXEL | 02 | N | 260029472 | IFOSFAMIDE + PACLITAXEL |
| 260018132 | 260009747 | null | null | Curative (C) | 2014-02-23 | 2014-03-11 | CYCLOPHOSPHAMIDE + VINORELBINE | N | null | 260029477 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 260018133 | 260009752 | 1.52 | 68 | Curative (C) | 2015-08-09 | 2015-10-11 | Cyclophosphamide High Dose | N | N | 260029507 | CYCLOPHOSPHAMIDE |
| 260018134 | 260009752 | 1.63 | 69.7 | Curative (C) | 2019-02-01 | 2019-02-02 | CYCLOPHOSPHAMIDE + FILGRASTIM | N | N | 260029507 | BENDAMUSTINE + OBINUTUZUMAB |
| 260018135 | 260009755 | 1.74 | 72 | Disease modification (D) | 2016-05-13 | 2016-05-13 | Gemcitabine + Paclitaxel | 02 | N | 260029509 | IPO |
| 260018136 | 260009756 | 1.5 | 45 | Disease modification (D) | 2018-07-22 | 2018-07-30 | ICE | N | null | 260029512 | BLEOMYCIN + VINCRISTINE |
| 260018137 | 260009765 | 1.82 | 66.9 | Adjuvant (A) | null | 2015-12-12 | VIP | 2 | N | 260029528 | IPO |
| 260018138 | 260009769 | 1.65 | 76.4 | null | 2020-01-05 | 2020-01-16 | CYCLOPHOSPHAMIDE + VINORELBINE | 02 | N | 260029532 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260018139 | 260009773 | 1.75 | 84 | Adjuvant (A) | 2016-09-23 | 2016-10-06 | BLEOMYCIN | N | N | 260029535 | CISPLATIN + EPIRUBICIN |
| 260018140 | 260009775 | 0 | 119.2 | Curative (C) | 2016-11-08 | 2016-11-08 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 260029557 | GEMCITABINE + TIP |
| 260018141 | 260009780 | 1.69 | 0 | Adjuvant (A) | 2018-02-15 | 2018-07-13 | OSIMERTINIB | N | N | 260029568 | GEMCITABINE |
| 260018142 | 260009784 | 1.88 | 75.6 | Adjuvant (A) | 2019-03-14 | 2019-03-14 | POMB | N | N | 260029571 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260018143 | 260009785 | 1.77 | 95.2 | Curative (C) | 2017-11-21 | 2017-11-21 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE | N | N | 260029587 | BLEOMYCIN + VINCRISTINE |